These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 14664900

  • 1. Plasma concentration of asymmetric dimethylarginine and the risk of coronary heart disease: rationale and design of the multicenter CARDIAC study.
    Mügge A, Hanefeld C, Böger RH, CARDIAC study investigators.
    Atheroscler Suppl; 2003 Dec; 4(4):29-32. PubMed ID: 14664900
    [Abstract] [Full Text] [Related]

  • 2. Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials.
    Böger RH.
    Vasc Med; 2005 Jul; 10 Suppl 1():S19-25. PubMed ID: 16444865
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.
    Böger RH, Bode-Böger SM, Sydow K, Heistad DD, Lentz SR.
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1557-64. PubMed ID: 10845872
    [Abstract] [Full Text] [Related]

  • 8. Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure.
    Ohnishi M, Wada A, Tsutamoto T, Fujii M, Matsumoto T, Yamamoto T, Takayama T, Wang X, Kinoshita M.
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():241S-244S. PubMed ID: 12193095
    [Abstract] [Full Text] [Related]

  • 9. Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in der Region Augsburg study and experimental data.
    Maas R, Schulze F, Baumert J, Löwel H, Hamraz K, Schwedhelm E, Koenig W, Böger RH.
    Clin Chem; 2007 Apr; 53(4):693-701. PubMed ID: 17317881
    [Abstract] [Full Text] [Related]

  • 10. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.
    Böger RH, Bode-Böger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP.
    Circulation; 1998 Nov 03; 98(18):1842-7. PubMed ID: 9799202
    [Abstract] [Full Text] [Related]

  • 11. ADMA and hyperhomocysteinemia.
    Dayal S, Lentz SR.
    Vasc Med; 2005 Jul 03; 10 Suppl 1():S27-33. PubMed ID: 16444866
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease.
    Böger RH, Zoccali C.
    Atheroscler Suppl; 2003 Dec 03; 4(4):23-8. PubMed ID: 14664899
    [Abstract] [Full Text] [Related]

  • 15. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease.
    Sahin M, Arslan C, Naziroglu M, Tunc SE, Demirci M, Sutcu R, Yilmaz N.
    Ann Clin Lab Sci; 2006 Dec 03; 36(4):449-54. PubMed ID: 17127734
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases.
    Böger RH, Bode-Böger SM.
    Semin Thromb Hemost; 2000 Dec 03; 26(5):539-45. PubMed ID: 11129410
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Asymmetric dimethylarginine (ADMA) a novel cardiovascular risk factor--evidence from epidemiological and prospective clinical trials.
    Szuba A, Podgórski M.
    Pharmacol Rep; 2006 Dec 03; 58 Suppl():16-20. PubMed ID: 17332667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.